MedTrace Logo

Comparison Between Gamma 3 Nail and ACE Trochanteric Nail

NCT00367406 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-12-20

No results posted yet for this study

Summary

Pertrochanteric and subtrochanteric femur fractures will be treated with a Gamma 3 nail or an ACE Trochanteric nail.

Following topics will be assessed: fracture consolidation, mobility, pain, walking power, agility.

Conditions

  • Pertrochanteric and Subtrochanteric Femur Fractures

Interventions

DEVICE

Gamma 3 nail versus ACE trochanteric nail

Comparing Gamma 3 nail versus ACE trochanteric nail

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • René Verdonk, MD, PhD · University Hospital, Ghent

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00367406 on ClinicalTrials.gov